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Objective: While there is recent interest in using re-
peated deep inspiratory breath-holds, or prolonged single
breath-holds, to improve radiotherapy delivery, breath-
holding has risks. There are no published guidelines for
monitoring patient safety, and there is little clinical
awareness of the pronounced blood pressure rise and
the potential for gradual asphyxia that occur during
breath-holding. We describe the blood pressure rise
during deep inspiratory breath-holding with air and test
whether it can be abolished simply by pre-oxygenation
and hypocapnia.
Methods:Wemeasured blood pressure, oxygen saturation
(SpO2) and heart rate in 12 healthy, untrained subjects
performing breath-holds.
Results: Even for deep inspiratory breath-holds with air,
the blood pressure rose progressively (e.g. mean systolic
pressure rose from 13365 to 17568mmHg at breakpoint,
p,0.005, and in two subjects, it reached 200mmHg).
Pre-oxygenation and hypocapnia prolonged breath-hold
duration and prevented the development of asphyxia but
failed to abolish the pressure rise. The pressure rise was
not a function of breath-hold duration and was not signalled
by any fall in heart rate (remaining at resting levels of
726 2 beats per minute).
Conclusion: Colleagues should be aware of the progres-
sive blood pressure rise during deep inspiratory breath-
holding that so far is not easily prevented. In breast cancer
patients scheduled for breath-holds, we recommend routine
screening for heart, cardiovascular, renal and cerebrovas-
cular disease, routine monitoring of patient blood pres-
sure and SpO2 during breath-holding and requesting
patients to stop if systolic pressure rises consistently
.180mmHg and or SpO2 falls ,94%.
Advances in knowledge: There is recent interest in using
deep inspiratory breath-holds, or prolonged single breath-
holding techniques, to improve radiotherapy delivery. But
there appears to be no clinical awareness of the risks to
patients from breath-holding. We demonstrate the pro-
gressive blood pressure rise during deep inspiratory
breath-holds with air, which we show cannot be prevented
by the simple expedient of pre-oxygenation and hypo-
capnia. We propose patient screening and safety guide-
lines for monitoring both blood pressure and SpO2 during
breath-holds and discuss their clinical implications.
There is recent clinical interest in using both deep in-
spiratory breath-holds and techniques for prolonging
breath-holding1 for patients undergoing radiotherapy or
imaging,2 with up to four radiology articles per week
mentioning breath-holding over the past 3 years. In par-
ticular, those with left breast cancer may undergo breath-
holding to spare the heart from exposure to radiation.
Sequentially repeated breath-holds with air of ca. 22 s are
generally used,2 but prolonged single breath-holds of
3–7min1,2 are now feasible.
Blood pressure is not routinely reported in such clinical
studies for radiotherapy or imaging,2,3 and we are not
aware of any consideration of its implications for patient
safety. There appears to be no clinical awareness of the
pronounced blood pressure rise (by 40mmHg or more)
that occurs during breath-holding.1,4–10 In young, other-
wise healthy patients, brief periods of such hypertension
are well tolerated. Patients requiring radiotherapy and
complex imaging are, however, typically from an older age
group and frequently have signiﬁcant coexisting disease.
Patients with atheromatous coronary artery plaques, aortic
disease or cerebrovascular disease are at particular risk from
sudden rises in systemic arterial blood pressure. Myocardial
infarction, aortic dissection/rupture and haemorrhagic stroke
are all potentially lethal complications in these patients. A sys-
tolic blood pressure .180mmHg is considered a “hypertensive
crisis” in current medical practice and is associated with a sig-
niﬁcant risk of end organ damage.11
Whilst multiple breath-holds and prolonged single breath-holding
techniques are not yet widely enough used to generate any lit-
erature or reporting of serious adverse effects in patients from
breath-holding, it is now prudent to consider safety guidelines
formally before adverse advents might occur.
We therefore describe the blood pressure rise during the clini-
cally used technique of breath-holding with air and have sought
a simple, non-pharmacological and non-invasive method of
preventing this rise. The conventional explanation is that the rise
is caused by hypoxia and hypercapnia (i.e. asphyxia) of breath-
holding stimulating systemic (peripheral) chemoreceptors.12–14
If this is correct, then the rise should be preventable because
breath-holding can be easily prolonged with hyperoxia and/or
hypocapnia.15
It might be expected that the pronounced blood pressure rise
during breath-holding would be signalled, by a corresponding
fall in heart rate (owing to baroreﬂex operation), which might
be easier to measure non-invasively than blood pressure. We
resolve the long-standing dispute over what happens to the
heart rate during simple breath-holding at rest1,6–9,16–18 by
using the latest techniques for instantaneous heart rate analysis
to show that the blood pressure rise is not signalled by any
corresponding fall in heart rate.
METHODS AND MATERIALS
Experiments were conducted following the Declaration of
Helsinki19 and the approval of the local research ethics com-
mittee in the Wellcome Trust Clinical Research Facility. 12
normal, healthy subjects (9 males and 3 females) aged 20–22
years, with no previous experience of breath-holding, lay at rest
in a semi-recumbent position and were instrumented15,20,21 to
measure blood pressure [Finapres 2300 Ohmeda (Finapres
Ohmeda, Englewood, CA) ﬁnger plethysmograph set at heart
level], chest electrocardiogram (lead I) and oxygen saturation
(SpO2; Nellcor™ ﬁnger pulse oximeter; Nellicor, Boulder, CA).
Subjects breathed through a face mask. Partial pressure of carbon
dioxide (PCO2) end tidal PCO2 (PetCO2) measurements from
in-line capnographs (Hewlett-Packard 78536A; Hewlett Pack-
ard, Palo Alto) conﬁrmed that subjects did not voluntarily
hyperventilate. They listened to music throughout. Data were
sampled at 2 kHz and analysed using a CED1401 data acquisition
system (Cambridge Electronics Design, Cambridge, UK). We
recorded 4min of eupnoeic breathing in room air preceding the
breath-hold. Subjects did not know when the breath-hold would
start and did not surreptitiously hyperventilate.
To mimic the deep inspiratory breath-holds used clinically,
subjects inhaled air maximally and held it as long as possible
with a relaxed posture. They did not attempt pushing or inhaling
against a closed glottis, as was easily conﬁrmed1,22 by observation
of their chest and neck and of their blood pressure record. The
order of experiments was not the same for every subject.
We also studied prolonged single breath-holds. This was ach-
ieved by pre-oxygenating subjects by their breathing 60% ox-
ygen (the maximum percentage of oxygen that may safely be
given without increasing the risk of atelectasis3,23) for 4min. It
was additionally achieved by rhythmically mechanically ven-
tilating them with positive pressure in 60% oxygen at 16
breaths per minute and at a tidal volume of approximately 1.2 l
(depending on their size) using a face mask connected to a
Drager Evita 2 ventilator; Drager, Luebeck, Germany.1,20,21
This induced 15min of hypocapnia at mean PetCO2 level of
206 0mmHg, the lowest level of hypocapnia that can be safely
induced without causing hypocapnic tetany.3,20,21,24
Each heart beat, blood pressure peak and trough were identiﬁed,
and continuous lines were plotted of instantaneous heart rate (in
beats per minute) peak, trough, peak trough difference (to then
derive respiratory sinus arrhythmia measured in milliseconds),
systolic, diastolic, mean pressure and SpO2. Instantaneous heart
rate analysis allows for the presence of respiratory sinus
arrhythmia1,9,15 and enabled us to resample all heart rate data at
the same frequency (8Hz was selected to resolve changes at up
to 200 beats per minute) to correctly align data in all subjects at
the same time points. To reveal any reﬂex effects that might ac-
celerate heart rate, from the effects of either the ﬁnal inﬂation
preceding the breath-hold and/or the breakpoint deﬂation/
inﬂation immediately following the breath-hold, data were also
sampled either from time zero that is the start of the maximal
inhalation before the breath-hold (where the breath-hold starts
at 13 s) or from time zero that is the start of the breakpoint
breath (where the breakpoint starts at 20.5 s). Breath-hold
durations were also normalized to 100%.
For statistical analysis using PASW® statistics v. 18 (SPSS Inc.,
Chicago, IL), the whole of the pre-breath-hold period was
compared with time periods as indicated in the ﬁgures. We used
a paired experimental design with each subject compared against
their own experimental. For each subject, their mean values in
these periods were compared using repeated measures analysis
of variance (ANOVA) using within subjects contrasts (with
.2000 points analysed per variable per subject) whose proba-
bility (p) values are cited in text and in ﬁgures. The ANOVA of
the SpO2 data used the non-parametric Friedman test. There
were no differences between males and females, and all data
were combined. Signiﬁcance was taken at p, 0.05 for two-tailed
tests, and the means for 12 subjects are given as6standard error
of the mean.
RESULTS
Breath-hold durations and gases
Over the 4-min rest period, mean systolic blood pressure was
1336 5mmHg, averaged mean pressure was 916 3mmHg and
diastolic pressure was 706 3mmHg, mean heart rate was 726 2
beats per minute, mean PetCO2 level was 396 1mmHg, mean
SpO2 was 996 0%, and they did not change throughout this
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period. As found previously,1,20,21 neither pre-oxygenation nor
this with hypocapnia changed the resting blood pressure or heart
rate.
The mean breath-holding duration was 1.46 0.2min with air,
2.86 0.4min with pre-oxygenation and 5.56 0.5min with pre-
oxygenation and hypocapnia.
Breath-holding with air resulted at breakpoint in a large rise in
systolic pressure (see below), slight arterial asphyxia, that is,
slight desaturation (mean SpO2 fell signiﬁcantly to reach a nadir
of 966 1%; p, 0.05 vs rest at 15 s post breakpoint) and hy-
percapnia (mean PetCO2 rose signiﬁcantly to 506 1mmHg;
p, 0.001 vs rest).
Pre-oxygenation prevented the desaturation of breath-holding
(mean SpO2 at breakpoint was 100%, non-signiﬁcant vs resting
levels). Such longer breath-holds caused greater hypercapnia
(mean PetCO2 was 536 1mmHg; p, 0.005 vs both rest and
breakpoint with air).
Pre-oxygenation and hypocapnia abolished the asphyxia of
breath-holding (at breakpoint mean SpO2 was 986 1% and
mean PetCO2 was 4362mmHg, both non-signiﬁcant vs resting
levels).
Blood pressure rises progressively during breath-
holding, even width pre-oxygenation and hypocapnia
Using the clinically used technique of deep inspiratory breath-
holds with air, Figures 1 and 2 show that blood pressure rose
progressively in all subjects during breath-holding. Mean sys-
tolic pressure at breakpoint for breath-holds with air was
1756 8mmHg, and in two subjects (Figure 1), it reached
200mmHg at breakpoint.
Figure 2 shows that the rise in blood pressure during breath-
holding is not caused by asphyxia, because the starting and ending
pressures, and hence the overall rises, are not signiﬁcantly dif-
ferent between breath-holds from air, from pre-oxygenation or
from pre-oxygenation and hypocapnia.
It was not the case that subjects with the longest breath-holds
had the highest pressure rises. The size of the blood pressure rise
was not obviously related simply to breath-hold duration. (The
r2 values between duration and the pressure rise were only 0.48,
0.06 and 0.20, while those between duration and the peak
pressure at breakpoint were only 0.23, 0.19 and 0.02 for each
breath-hold category.)
The blood pressure rise is not signalled by a fall in
heart rate during breath-holding
Figures 1 and 2 show that the blood pressure rise is not signalled
by a fall in heart rate during breath-holding; that is, it does not
cause heart rate to fall. No heart rate fall is detectable even in
the subject with the longest breath-hold (approximately 9min),
yet we could successfully detect other changes in the heart rate
when expected (e.g. the inﬂation preceding the breath-hold with
air causes a signiﬁcant increase in mean heart rate, reaching
926 3 beats per minute in the 2nd second, and that the 1st
exhalation/inﬂation causes a signiﬁcant increase in heart rate,
reaching 846 3 beats per minute in the 5th second).
DISCUSSION
Pre-oxygenation and hypocapnia fail to abolish the
progressive blood pressure rise during breath-holding
Deep inspiratory breath-holds with air are currently used clin-
ically, and we show the substantial blood pressure rise that
occurs, about which there is no warning in current radiotherapy
literature.
Our subjects did try hard to breath-hold as long as possible,
as shown by the fact that their breath-hold durations and
breakpoint PetCO2 levels are as good or better than in pre-
vious studies,15,25 that arterial desauration occurred and by
how high PetCO2 rose. Neither is the blood pressure rise caused
by subjects straining against a closed glottis (the Valsalva ma-
noeuvre) during breath-holding, because we conﬁrmed that
none did this.
We are the ﬁrst to show that this blood pressure rise cannot be
prevented by pre-oxygenation and hypocapnia. Thus, the con-
ventional explanation, that it is caused by asphyxia stimulating
peripheral chemoreceptors,13,14 is incorrect. Instead, the pres-
sure rise without heart rate falling may be caused by a muscle
metaboloreﬂex originating in the holding muscle, the diaphragm.15
It is disappointing that the pressure rise cannot be prevented by
this simple, non-invasive expedient. We do not recommend
pharmacological manipulation of autonomic function nor se-
dation during breath-holding to prevent it, not only because of
the further complications of additional medication but also
because the involuntary breakpoint mechanism15 is itself a
safety feature and should not be suppressed.
Clinical importance for patient safety in radiotherapy
of the blood pressure rise during breath-holding
Although, recently, there is widespread clinical interest in using
multiple deep inspiratory breath-holds, or prolonged single
breath-holds to improve imaging and radiotherapy,1,2 we un-
derstand that patients’ blood pressure is neither recorded nor
reported routinely (see Roth et al2 and the record 14-min breath-
hold by Klocke and Rahn3). Moreover, the ability of standard
non-invasive blood pressure monitors placed on the arm to
reveal the precise pressure rise is limited. This is because, since
most breath-holds currently used during radiotherapy and im-
aging are so short (approximately 22 s duration2), there is only
enough time for approximately two measurements. We do not
advocate arterial cannulation. The non-invasive devices that
continuously estimate blood pressure for each heart beat (such
as Finapres) do, however, appear to provide the best indication
so far of the time course of the pressure rise.
We also show that routine and non-invasive monitoring of the
patient’s heart rate cannot warn of this blood pressure rise.
Thus, we show that heart rate does not change during breath-
holding with air (resolving the long standing dispute18 about
what happens to heart rate during breath-holding). Our
Full paper: Assessing patient safety during breath-holding BJR
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conclusion is conﬁrmed by the many studies showing that car-
diac output does not fall below normal resting levels of approx-
imately 6 l per minute6,8,10 during breath-holding and neither
can venous return be impeded sufﬁciently to alter heart rate.
Our more detailed analysis also reveals how previous, simpler
heart rate analyses might ﬁnd either no heart rate change or
rises or falls.1,6–10,13,14,16,26–30
Although presently most deep inspiratory breath-holds for radio-
therapy and imaging are of only approximately 22 s duration,2 we
counsel caution for three reasons. First, we do not yet know
what happens to blood pressure in such patients, because no
previous studies measured it nor report the patient’s maximum
breath-hold duration. Since we do not know how near these
patients were to their breakpoint, we cannot even estimate from
Figure 1. Blood pressure rises progressively (without heart rate falling) in the subject with the longest breath-hold. Original
polygraph record [with the breath-hold indicated by the absence of partial pressure of carbon dioxide (PCO2) fluctuations]. Note
the similar pressure rise without heart rate falling for all breath-holds and the slight arterial desaturation following the deep
inspiratory breath-hold with air. bpm, beats per minute; SpO2, oxygen saturation.
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our data how high their blood pressure might rise. Secondly,
such studies often ask patients to breath-hold repeatedly31 and
the cumulative effects of multiple breath-holds on blood pressure
have yet to be measured. Thirdly, if patients already have hy-
pertension, the additional effects of breath-holding on blood
pressure might be problematic.
We believe that the primary clinical requirement is simply a
greater awareness of the implications of the progressive blood
pressure rise for patient safety during breath-holding for radio-
therapy. Although pressure does become acutely high, it returns
to resting levels approximately 15 s after the breakpoint. Such
transient rises in blood pressure are likely to be well tolerated
by most patients, but those with pre-existing coronary artery
disease, cerebrovascular disease, including cerebral artery aneur-
ysms, aortic disease and long-standing hypertensive end organ
damage are all at signiﬁcant risk of injury from blood pressure
rises of this magnitude.
Not only does pressure rise, but breath-holds without pre-
oxygenation also cause arterial oxygen desaturation. While
moderate desaturation to no lower than 90% is very unlikely
to produce any longstanding effects, patients with coexisting
ischaemic coronary artery disease or cerebrovascular disease are
at risk from permanent damage from episodes of hypoxia. The
exact level at which arterial hypoxaemia becomes dangerous
varies from patient to patient and is not well understood. With
non-invasive monitoring (the ﬁnger pulse oximeter), the full
extent of this is only apparent at 15 s after the breakpoint
(some of this delay being a consequence of the averaging used
by pulse oximeters that delays their response time to rapidly
changing arterial saturations). Thus, even if a breath-hold is
terminated once SpO2 reaches 94%, saturation continues to fall at
an increasing rate as normal breathing continues, before even-
tually stabilizing and rising again. Taking the simple step of
monitoring any fall in arterial saturation during breath-holding
is, however, prudent. Moreover, we demonstrate that pre-
oxygenation with 60% oxygen will prevent any desaturation dur-
ing even the longest breath-holds.
In conclusion, we show that a clinically signiﬁcant blood
pressure rise occurs during deep inspiratory breath-holds.
This rise cannot be prevented by pre-oxygenation and
hypocapnia. For breast cancer patients scheduled for deep
inspiratory breath-holds, and particularly for prolonged
breath-holds, we therefore recommend routine screening for
heart, cardiovascular, renal and cerebrovascular disease. We
also recommend routine blood pressure and SpO2 monitor-
ing before breath-holds and greater awareness of the possible
pressure rises during prolonged breath-holding in such
patients, particularly, those with cardiovascular and/or ce-
rebrovascular comorbidity. We also recommend adoption of
safety limits, where all patients are requested to stop breath-
holding if systolic pressure consistently exceeds 180mmHg and/or
SpO2 falls ,94%.
CONFLICTS OF INTEREST
The views expressed are those of the authors and not neces-
sarily those of the National Health Service, the National In-
stitute for Health Research or the Department of Health.
FUNDING
This article was supported by Queen Elizabeth Hospital Bir-
mingham Charity.
ACKNOWLEDGMENTS
We are grateful for the support from the Queen Elizabeth
Hospital Birmingham Charity. We are grateful to Cambridge
Electronic Design Ltd, to Dr David McIntyre and to Peter Night-
ingale for their help with programming and statistical analysis
and to Dr Una Martin and the staff at the National Institute for
Health Research (NIHR)/Wellcome Trust Birmingham Clinical
Research Facility.
Figure 2. Averaged systolic blood pressure (sBP) rises pro-
gressively (without averaged instantaneous heart rate falling) in
12 subjects. Breath-hold duration is normalized to 100% for
each subject, with grey lines indicating breath-holds with air,
thin lines indicating breath-holds with 60% oxygen and thick
lines indicating breath-holds with 60% oxygen and hypocapnia.
Vertical dashed lines indicate the start and end of the breath-
hold. nsp.0.05; †p,0.005 vs the mean value over the 4min of
pre-breath-hold, with upper symbol indicating breath-holds
with air; middle indicating breath-holds with 60% oxygen;
lower indicating 60% oxygen and hypocapnia. bpm, beats per
minute.
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